The b-carboline harmine is an immunomodulator in cutaneous leishmaniasis favoring the balance towards a protective immune response
Ontology highlight
ABSTRACT: Here, we investigated the impact of synthetic b-carboline harmine (ACB1801), on the immune response and pathology resulting from infection with a drug-resistant Leishmania major strain causing non-healing cutaneous lesion. Exposure to ACB1801 impacted only slightly parasite viability and parasite burden in host macrophages in vitro. However, it significantly increased MHC-II and co stimulatory molecules expression on infected DCs, suggesting enhanced immune response. Accordingly, ACB1801 monotherapy significantly decreased lesion development and parasite burden in Leishmania infected C57BL/6 mice, with similar efficacy than the widely used Amphotericin B therapy. ACB1801 impact on the immune response was validated by transcriptomics analysis showing enrichment of TNF-a, IFN-g and MHC-II Ag presentation signatures in the draining lymph nodes of treated mice. Increased frequency of protective CD4+IFN-g+TNF-α+ T cells and reduced suppressive IL-10+FoxP3- T cells was observed by flow cytometry. ACB1801 was further shown to act via the downregulation of Aryl hydroxyl receptor (AhR) signaling, decreasing immunosuppressive cytokines. Thus, these results suggest a potential use for ACB1801 alone or in combination therapy.
ORGANISM(S): Mus musculus
PROVIDER: GSE236962 | GEO | 2023/10/24
REPOSITORIES: GEO
ACCESS DATA